TD Cowen raised the firm’s price target on McKesson to $652 from $563 and keeps a Buy rating on the shares. The firm said they believe the company remains well-positioned for continued momentum across its core businesses, as well as to leverage unique growth opportunities, such as the Optum contract win and GLP-1 growth opportunity in CoverMyMeds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: